Possible involvement of microglia containing cyclooxygenase-1 in the accumulation of gonadotrophin-releasing hormone in the preoptic area in female rats

J Neuroendocrinol. 2009 Dec;21(12):1029-37. doi: 10.1111/j.1365-2826.2009.01928.x. Epub 2009 Oct 20.

Abstract

Prostaglandins (PGs), especially PGE(2), are involved in the hypothalamic control of gonadotrophin-releasing hormone (GnRH) release, acting at least in part on the terminal of GnRH axons in the median eminence. The present study aimed: (i) to clarify the role of PG(s) in regulating GnRH cell function at the level of the perikarya in the preoptic area; (ii) to determine the cyclooxygenase (COX) isozyme responsible for producing PG(s) that regulates GnRH perikarya; and (iii) to identify cell types that contain the responsible COX isozyme in female rats. A surge of luteinising hormone (LH) secretion was induced by oestrogen and progesterone in ovariectomised rats. Treatment of the rat before the LH surge with indomethacin, a nonselective COX inhibitor, or NS-398, a selective COX-2 inhibitor, did not interfere with the surge. However, treatment with indomethacin or flurbiprofen, a selective COX-1 inhibitor, significantly reduced the number of GnRH-immunoreactive cells in the preoptic area at the time of peak LH secretion during the surge. NS-398 did not affect the GnRH immunoreactivity. Double-labelled immunofluorescent histochemistry revealed COX-1 immunoreactivity in the vicinity of, but not within, GnRH containing neurones in the preoptic area. COX-2 immunoreactivity was not found in the same area. The COX-1 immunoreactivity was almost entirely localised in microglia in the preoptic area, but not in neurones or astrocytes. These results suggest that microglia in the preoptic area containing COX-1 are responsible for producing PG(s), which, in turn, facilitates the accumulation of GnRH during the gonadotrophin surge in female rats.

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / physiology
  • Cyclooxygenase 1 / metabolism*
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Estrogens / metabolism
  • Female
  • Flurbiprofen / pharmacology
  • Gonadotropin-Releasing Hormone / metabolism*
  • Indomethacin / pharmacology
  • Luteinizing Hormone / metabolism
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / metabolism*
  • Microglia / drug effects
  • Microglia / physiology*
  • Neurons / drug effects
  • Neurons / physiology
  • Nitrobenzenes / pharmacology
  • Ovariectomy
  • Preoptic Area / drug effects
  • Preoptic Area / physiology*
  • Progesterone / metabolism
  • Rats
  • Rats, Wistar
  • Sulfonamides / pharmacology
  • Time Factors

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Estrogens
  • Membrane Proteins
  • Nitrobenzenes
  • Sulfonamides
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Gonadotropin-Releasing Hormone
  • Progesterone
  • Flurbiprofen
  • Luteinizing Hormone
  • Cyclooxygenase 1
  • Ptgs1 protein, rat
  • Indomethacin